FDA 503B outsourcing facilities in Puerto Rico
Puerto Rico has 1 FDA-registered 503B outsourcing facility in the PeptideGrids directory, none with FDA drug recalls on record, the earliest registered in 2026. 503B facilities compound sterile medications in bulk under FDA cGMP standards and are a primary supply route for compounded peptides and GLP-1s during drug shortages.
| Facility | City | FDA-registered since | FDA recalls |
|---|---|---|---|
| Ocyon Bio PR, LLC | Aguadilla | 2026 | None on record |
503B compounding in Puerto Rico
A 503B outsourcing facility registers with the FDA under the Drug Quality and Security Act and is inspected against cGMP manufacturing standards. In addition to that federal registration, a facility shipping into or operating in Puerto Rico must hold the appropriate state pharmacy license. Verify any facility's current license with the Puerto Rico Department of Health.
Compounded peptides and GLP-1s
503B facilities are a primary supply route for compounded peptides and GLP-1s, including Semaglutide, Tirzepatide, BPC-157, Retatrutide. Browse the full GLP-1 and therapeutic peptide databases, or the national directory.
Frequently asked questions
How many FDA 503B outsourcing facilities are in Puerto Rico?
1 FDA-registered 503B outsourcing facility is listed in Puerto Rico on PeptideGrids, the earliest registered in 2026.
Which Puerto Rico 503B facilities have FDA recalls on record?
None of the Puerto Rico facilities in our directory have FDA drug recalls on record.
How do I verify a pharmacy license in Puerto Rico?
Use the Puerto Rico Department of Health license lookup to confirm a facility's current license status.
Facilities sourced from the FDA registered outsourcing facilities list. Recall counts from the FDA openFDA drug enforcement database.